Our pharmaceutical division collaborates with top-tier pharmaceutical firms, developing and providing specialty medications in diverse clinical domains such as pulmonology, dermatology, pediatrics, and orthopedics. Moreover, we supply an array of over-the-counter drugs and health-functional foods, including our pioneering gargle-type oral inflammation remedy “Afinibenq” and the three-ingredient constipation solution “Bicogreen S-tablet”. Many of our products consistently rank between 1st to 3rd in market share, testifying to their recognized value.
Our new drug development division continually identifies novel targets via orthotopic modeling and clinical translational research. We ensure precise pre-clinical trials that amplify reproducibility during clinical phases. With these foundations, we aim to elevate the clinical competencies of domestic biotech firms. Our diverse and expandable pipeline has been built through continuous collaboration with various partner entities.
At Kolon Pharma, our vision is to strengthen our pharmaceutical business and new drug development sectors, aspiring to emerge as a global pharma-bio powerhouse.
Company Details
- Employees
- 3
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.kolonpharm.co.kr/
Kolon Pharma Questions
Kolon Pharma's website is https://www.kolonpharm.co.kr/
Kolon Pharma's LinkedIn profile is https://www.linkedin.com/company/kolonpharma
Kolon Pharma has
3 employees.
View email and phone details for 3
employees at Kolon Pharma.
Kolon Pharma's industry is
Pharmaceutical Manufacturing
Kolon Pharma's top competitors are
Samsung Biologics,
Metropolitan Council Of The Twin Cities,
Kolon Pharma,
Ildong Pharmaceutical Company.
Kolon Pharma's categories are Pharmaceutical Manufacturing
Kolon Pharma's founding year is 1958
